Catalina Capital Group LLC Takes $245,000 Position in Haleon plc (NYSE:HLN)

Catalina Capital Group LLC acquired a new position in shares of Haleon plc (NYSE:HLN) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 25,685 shares of the company’s stock, valued at approximately $245,000.

Other hedge funds also recently bought and sold shares of the company. Fortitude Family Office LLC acquired a new stake in shares of Haleon during the third quarter valued at approximately $28,000. Versant Capital Management Inc lifted its holdings in shares of Haleon by 2,029.1% in the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company’s stock valued at $34,000 after purchasing an additional 3,348 shares in the last quarter. Geneos Wealth Management Inc. acquired a new stake in shares of Haleon in the fourth quarter worth $35,000. Toronto Dominion Bank grew its holdings in shares of Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company’s stock valued at $38,000 after buying an additional 3,470 shares in the last quarter. Finally, Spire Wealth Management acquired a new position in Haleon during the fourth quarter valued at $39,000. 6.67% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on HLN. Morgan Stanley lowered Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein cut shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $10.95.

Haleon Stock Performance

Shares of NYSE HLN opened at $9.48 on Tuesday. Haleon plc has a one year low of $7.89 and a one year high of $10.80. The business’s 50-day moving average price is $9.54 and its two-hundred day moving average price is $9.77. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.84 and a quick ratio of 0.58. The company has a market capitalization of $42.89 billion, a P/E ratio of 27.87, a price-to-earnings-growth ratio of 2.69 and a beta of 0.28.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.